Edwards Lifesciences vs Steris
Edwards Lifesciences and Steris are similar in size: $6.07bn and $5.94bn of revenue in their latest fiscal years. Edwards Lifesciences grew faster (11.5% against 8.7%). Edwards Lifesciences kept more of each dollar of sales as profit: a net margin of 17.7% against 13.2%.
| Latest fiscal year | Edwards LifesciencesEW, 2025 | SterisSTE, 2026 |
|---|---|---|
| Revenue | $6.07bn | $5.94bn |
| Revenue growth | 11.5% | 8.7% |
| Net income | $1.07bn | $782m |
| Operating margin | — | 18.6% |
| Net margin | 17.7% | 13.2% |
| Return on equity | 10.6% | 11.3% |
| Free cash flow | $1.33bn | $972m |
| Cash | $2.94bn | $440m |
| Total debt | $598m | $1.93bn |
| Debt to equity | — | 26.9% |
| Dividend per share | — | $2.46 |
| Dividend yield | — | 1.1% |
| Share buybacks | $893m | $236m |
| Employees | 16,000 | 16,000 |
| Market value | $53.77bn | $22.75bn |
| Price vs our value range | Above our value range | Within our value range |
| Moat score | 96 (Strong) | 70 (Moderate) |
| Insider trades, 12 months | 0 buys, 54 sales | 0 buys, 12 sales |